Last updated on February 2017

A Study of RPL554 in Patients With Cystic Fibrosis


Brief description of study

This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis. All patients receive all three treatments in a randomised sequence.

Clinical Study Identifier: NCT02919995

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Andres Floto

Papworth Hospital
Cambridge, United Kingdom
  Connect »